查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
輸血診斷市場2028年前的預測-COVID-19影響與產品，應用，各終端用戶的全球分析
市場調查報告書
商品編碼
1118307

輸血診斷市場2028年前的預測-COVID-19影響與產品，應用，各終端用戶的全球分析

Blood Transfusion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 183 Pages | 訂單完成後即時交付

價格

輸血診斷的全球市場在2021年估算為40億9693萬美元，到2028年達到64億8375萬美元。市場在2022年～2028年間，預測將以年複合成長率6.9％。關於促進本報告提供市場成長的一般的趨勢與要素拿起著。

本報告提供全球輸血診斷市場相關調查，提供市場概要，以及各產品，應用，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

  • 調查目標範圍
  • Insight Partners的調查報告書指導
  • 市場區隔
    • 輸血診斷的全球市場-各產品
    • 輸血診斷的全球市場-各應用領域
    • 輸血診斷的全球市場-各終端用戶
    • 輸血診斷的全球市場-各地區

第2章 輸血診斷市場 - 主要點

第3章 調查手法

  • 目標範圍
  • 2次調查
  • 1次調查

第4章 輸血診斷市場 - 市場形勢

  • PEST分析
    • 北美PEST分析
    • 歐洲PEST分析
    • 亞太地區的PEST分析
    • 中東·非洲PEST分析
    • 中南美PEST分析
  • 專家的見解

第5章 輸血診斷市場 - 主要市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 今後趨勢
  • 促進因素和阻礙因素的影響分析

第6章 輸血診斷市場 - 世界分析

  • 輸血診斷的世界市場收益預測與分析
    • 輸血診斷的全球市場收益和預測及分析
    • 輸血診斷的全球市場-市場潛在力分析，各地區
  • 輸血診斷市場上主要企業的市場佔有率分析
    • 企業分析
    • 成長策略分析
    • 主要企業的業績
      • guriforusuS.A.
      • F.霍夫曼·la·Roche公司

第7章 輸血診斷市場分析與2028年前的預測 - 各產品

  • 輸血診斷市場各產品收益佔有率(2021年，2028年)
  • 設備·套件
  • 試劑

第8章 輸血診斷市場分析-各用途

  • 輸血診斷市場各應用領域收益佔有率(2021年，2028年)
  • 疾病篩檢
  • 血型

第9章 輸血診斷市場分析- 各終端用戶

  • 輸血診斷市場各終端用戶佔有率(2021年，2028年)(%)
  • 血液銀行
  • 醫院
  • 診斷實驗室
  • 血漿分餾企業

第10章 到2028年前的輸血診斷市場收益與預測 - 各地區分析

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中南美
    • 巴西
    • 阿根廷
    • 其他的中南美地區
  • 中東·非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 其他的中東·非洲地區

第11章 COVID-19疫情對輸血診斷市場帶來的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 中南美
  • 中東和非洲

第12章 輸血診斷市場-產業形勢

  • 輸血診斷市場上成長策略
  • 無機性的成長策略
  • 內部成長策略

第13章 企業簡介

  • Grifols, S.A.
  • F. Hoffmann-La Roche Ltd
  • Immucor, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Thermo Fisher Scientific Inc.
  • Ortho Clinical Diagnostics(QuidelOrtho Corporation)
  • DiaSorin S.p.A.
  • Quotient Limited
  • BAG Diagnostics GmbH

第14章 附錄

  • 關於見解·同伴
  • 用語說明
Product Code: TIPRE00005176

The global blood transfusion diagnostics market is expected to grow from US$ 4,096.93 million in 2021 to US$ 6,483.75 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028. The report highlights prevailing trends and factors driving the market growth.

The growth of the global blood transfusion diagnostics market is attributed to the rapid increase in chronic diseases and the need for blood transfusion due to the rise in organ transplant surgeries. However, the problems associated with blood transfusion services hinder the overall market growth.

Blood transfusion diagnostics refers to tests performed on blood and blood components before they are transfused to patients. A blood transfusion is a common procedure in which donated blood or blood components are transfused into the patient's body through an intravenous line (IV). Each unit of blood must undergo blood typing, which refers to identification of blood type and blood screening, including disease detection tests to avoid side effects or transmission of infection. Blood screening before transfusion is performed through instruments, kits, and reagents to identify various diseases, such as HIV, hepatitis B, hepatitis C, Zika, and different viruses and infections.

According to the data published by the National Institute of Cancer Prevention and Research (NICPR) and the Indian Council of Medical Research (ICMR), the yearly prevalence of cancer in India is estimated at ~2.25 million, leading to numerous surgical procedures.

As per a 2019 study, titled "Challenges of blood transfusions in B-thalassemia," approximately 26,000 patients with transfusion-dependent B-thalassemia (TDT) are born every year, and around 90% of these births occur in low- or middle-income countries. Hemoglobinopathies, comprising sickle cell disease, are endemic in Africa, Asia, the Middle East, the Indian subcontinent, and the Mediterranean region. They are currently the most common rare inherited genetic diseases in Europe. Due to migration, hemoglobinopathies have been increasingly common in parts of North America and Northern and Western Europe, where they are not indigenous, and in their indigenous countries of Southern Europe. This led to an increase in the prevalence of B-thalassemia. Approximately 800 patients with thalassemia are registered in the UK National Haemoglobinopathy Registry, with around 500 patients undergoing regular blood transfusions. Therefore, blood transfusion diagnostics are widely used in various surgical procedures, such as cardiac surgery and other invasive procedures.

Chronic diseases, such as cancer, cardiovascular diseases, and renal disorders, are major causes of human death worldwide. These conditions are generally treated via surgical procedures, which are associated with a chance of excessive blood loss. Fresh blood is infused into patients to maintain their blood levels. Blood transfusion diagnostics are used during the blood infusion or reinfusion processes. Hence, the global blood transfusion diagnostics market is rising with the rapid increase in chronic diseases.

Based on product, the global blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. In 2021, the instruments & kits segment held a larger market share. The same segment is expected to register a higher CAGR in the market from 2022 to 2028. Based on application, the market is bifurcated into disease screening and blood grouping. The disease screening segment held a larger market share in 2021 and is expected to register a higher CAGR during the forecast period. Based on end user, the market is segmented into blood banks, hospitals, diagnostic laboratories, and plasma fractionation companies. The blood banks segment held the largest market share in 2021. The same segment is expected to register the highest CAGR in the global blood transfusion diagnostics market from 2022 to 2028.

Impact of COVID-19 Pandemic on Global Blood Transfusion Diagnostics Market

The COVID-19 pandemic negatively impacted blood services operations worldwide. Blood collection was affected due to the decrease in donor availability caused by avoidance of public places, social distancing policies, and cancellation of blood drives. The negative impact on blood collection led to a reduction in blood transfusion due to insufficient blood supply. For instance, a research conducted by RMIT University, Australia, titled "The Impact of COVID-19 on Blood Transfusion Services: A Systematic Review and Meta-Analysis," revealed that the average decrease in blood donations was found to be 38% in the country. To cope with the blood shortage, campaigns were implemented to appeal for blood donation, raise public awareness about the importance of blood donation, and gain donors' confidence in safe blood donation. For instance, upon Korean Red Cross Blood Services' (KRCBS) request, the Ministry of Health and Welfare (MoHW) approved the relaxation of the geographical restrictions regarding indigenous malaria, thus enabling the collection of more than 23,000 units of whole blood.

Furthermore, doctors took the initiative to control unnecessary blood transfusions. For instance, according to the news published by ABC Science, in March 2022, Australian doctors warned against unnecessary blood transfusions in Australian hospitals. Also, as medical and surgical practices were restricted, the need for blood transfusions was decreased too. Thus, the above factors and instances indicate that the blood transfusion diagnostic market witnessed a negative COVID-19 impact.

Various organic and inorganic strategies are adopted by companies operating in the global blood transfusion diagnostics market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few significant developments by key players in the global blood transfusion diagnostics market are listed below.

In July 2022, Quotient Limited announced an agreement with InfYnity Biomarkers, an R&D firm dedicated to utilizing biomarkers for managing infectious and immunology diseases. The two companies will partner to advance the safety and effectiveness of infectious disease testing by leveraging Quotient's MosaiQ solution.

In November 2021, Roche announced the launch of the cobas 5800 System, a new molecular laboratory instrument, in countries accepting the CE mark. The cobas 5800 System helps address challenges that laboratories are facing from increased patient testing, reimbursement complexities, and the need for a more diverse testing menu while providing meaningful and timely results.

While preparing the report on the global blood transfusion diagnostics market, a few major primary and secondary sources are the National Health and Medical Research Council (NHMRC), the Government of Canada, and the Kidney Research and Clinical Practice (KRCP).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the blood transfusion diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the blood transfusion diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Blood Transfusion Diagnostics Market - By Product
    • 1.3.2 Global Blood Transfusion Diagnostics Market - By Application
    • 1.3.3 Global Blood Transfusion Diagnostics Market - By End User
    • 1.3.4 Global Blood Transfusion Diagnostics Market - By Geography

2. Blood Transfusion Diagnostics Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Blood Transfusion Diagnostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South & Central America PEST Analysis
  • 4.3 Experts Opinion

5. Blood Transfusion Diagnostics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rapid Increase in Chronic Diseases
    • 5.1.2 Need For Blood Transfusion due to Rise in Organ Transplants Surgeries
  • 5.2 Market Restraints
    • 5.2.1 Problems associated with Blood Transfusion Services
  • 5.3 Market Opportunities
    • 5.3.1 Elevated Healthcare Expenditure in Emerging Economies
    • 5.3.2 Growing Initiatives by Governments
  • 5.4 Future Trends
    • 5.4.1 Technological Developments in Blood Transfusion Diagnostics
  • 5.5 Impact Analysis

6. Blood Transfusion Diagnostics Market- Global Analysis

  • 6.1 Global Blood Transfusion Diagnostics Market Revenue Forecast and Analysis
    • 6.1.1 Global Blood Transfusion Diagnostics Market Revenue Forecast and Analysis
    • 6.1.2 Global Blood Transfusion Diagnostics Market - Market Potential Analysis, By Region
  • 6.2 Market Share Analysis of Key Players in Blood Transfusion Diagnostics Market
    • 6.2.1 Company Analysis
    • 6.2.2 Growth Strategy Analysis
    • 6.2.3 Performance of Key Players
      • 6.2.3.1 Grifols S.A.
      • 6.2.3.2 F. Hoffmann-La Roche Ltd

7. Blood Transfusion Diagnostics Market Analysis and Forecasts To 2028 - By Product

  • 7.1 Overview
  • 7.2 Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
  • 7.3 Instruments and Kits
    • 7.3.1 Overview
    • 7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • 7.4 Reagents
    • 7.4.1 Overview
    • 7.4.2 Reagents: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

8. Blood Transfusion Diagnostics Market Analysis - By Application

  • 8.1 Overview
  • 8.2 Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
  • 8.3 Disease Screening
    • 8.3.1 Overview
    • 8.3.2 Disease Screening: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • 8.4 Blood Grouping
    • 8.4.1 Overview
    • 8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

9. Blood Transfusion Diagnostics Market Analysis - By End User

  • 9.1 Overview
  • 9.2 Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)
  • 9.3 Blood Banks
    • 9.3.1 Overview
    • 9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Hospitals
    • 9.4.1 Overview
    • 9.4.2 Hospitals: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • 9.5 Diagnostic Laboratories
    • 9.5.1 Overview
    • 9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Plasma Fractionation Companies
    • 9.6.1 Overview
    • 9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

10. Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 10.1 North America: Blood Transfusion Diagnostics Market
    • 10.1.1 Overview
    • 10.1.2 North America: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    • 10.1.3 North America: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
    • 10.1.4 North America: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
    • 10.1.5 North America: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
    • 10.1.6 North America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
      • 10.1.6.1 US: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.6.1.1 US: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.6.1.2 US: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
        • 10.1.6.1.3 US: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
        • 10.1.6.1.4 US: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 10.1.6.2 Canada: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.6.2.1 Canada: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.6.2.2 Canada: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
        • 10.1.6.2.3 Canada: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
        • 10.1.6.2.4 Canada: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 10.1.6.3 Mexico: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.6.3.1 Mexico: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.6.3.2 Mexico: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
        • 10.1.6.3.3 Mexico: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
        • 10.1.6.3.4 Mexico: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
  • 10.2 Europe: Blood Transfusion Diagnostics Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    • 10.2.3 Europe: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
    • 10.2.4 Europe: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
    • 10.2.5 Europe: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
    • 10.2.6 Europe: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
      • 10.2.6.1 Germany: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.1.1 Germany: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.1.2 Germany: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
        • 10.2.6.1.3 Germany: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
        • 10.2.6.1.4 Germany: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 10.2.6.2 UK: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.2.1 UK: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.2.2 UK: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
        • 10.2.6.2.3 UK: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
        • 10.2.6.2.4 UK: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 10.2.6.3 France: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.3.1 France: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.3.2 France: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
        • 10.2.6.3.3 France: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
        • 10.2.6.3.4 France: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 10.2.6.4 Italy: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.4.1 Italy: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.4.2 Italy: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
        • 10.2.6.4.3 Italy: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
        • 10.2.6.4.4 Italy: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 10.2.6.5 Spain: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.5.1 Spain: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.5.2 Spain: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
        • 10.2.6.5.3 Spain: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
        • 10.2.6.5.4 Spain: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
      • 10.2.6.6 Rest of Europe: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.6.1 Rest of Europe: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.2.6.6.2 Rest of Europe: Blood Transfusion Diagnostics Market, by Product, 2019-2028 (USD Million)
        • 10.2.6.6.3 Rest of Europe: Blood Transfusion Diagnostics Market, by Application, 2019-2028 (USD Million)
        • 10.2.6.6.4 Rest of Europe: Blood Transfusion Diagnostics Market, by End User, 2019-2028 (USD Million)
  • 10.3 Asia Pacific Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    • 10.3.4 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
    • 10.3.5 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
    • 10.3.6 Asia Pacific: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
      • 10.3.6.1 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.1.3 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.3.6.1.4 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.1.5 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 10.3.6.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.2.3 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.3.6.2.4 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.2.5 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 10.3.6.3 India Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.3.3 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.3.6.3.4 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.3.5 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 10.3.6.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.3.6.4.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.4.5 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 10.3.6.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.3.6.5.4 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.5.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • 10.4 South and Central America Blood Transfusion Diagnostics Market
    • 10.4.1 Overview
    • 10.4.2 South and Central America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 South and Central America Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    • 10.4.4 South and Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
    • 10.4.5 South and Central America: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.6 South and Central America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
      • 10.4.6.1 Brazil: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 Brazil Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.3 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.4.6.1.4 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.4.6.1.5 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
      • 10.4.6.2 Argentina: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 Argentina Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.3 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.4.6.2.4 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.4.6.2.5 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
      • 10.4.6.3 Rest of the South and Central America: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 Rest of the South and Central America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.3 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.4.6.3.4 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.4.6.3.5 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
  • 10.5 Middle East & Africa Blood Transfusion Diagnostics Market
    • 10.5.1 Overview
    • 10.5.2 Middle East & Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 10.5.3 Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    • 10.5.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
    • 10.5.5 Middle East & Africa: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.6 Middle East & Africa: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
      • 10.5.6.1 South Africa: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 South Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.3 South Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.5.6.1.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.5.6.1.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)
      • 10.5.6.2 Saudi Arabia: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Saudi Arabia Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.3 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.5.6.2.4 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.5.6.2.5 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
      • 10.5.6.3 UAE: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 UAE: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.3 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.5.6.3.4 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.5.6.3.5 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
      • 10.5.6.4 Rest of the Middle East and Africa: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 10.5.6.4.1 Overview
        • 10.5.6.4.2 Rest of the Middle East and Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.4.3 Rest of Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 10.5.6.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
        • 10.5.6.4.5 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)

11. Impact of COVID-19 Pandemic on Blood Transfusion Diagnostics Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
  • 11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Blood Transfusion Diagnostics Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Blood Transfusion Diagnostics Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Grifols, S.A.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 F. Hoffmann-La Roche Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Immucor, Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Bio-Rad Laboratories, Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Abbott
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Thermo Fisher Scientific Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 DiaSorin S.p.A.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Quotient Limited
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 BAG Diagnostics GmbH
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Mexico: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Europe: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Germany: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. UK: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. UK: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. France: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Italy: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Rest of Europe: Blood Transfusion Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Blood Transfusion Diagnostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million).
  • Table 35. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 36. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 37. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 38. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 39. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 40. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 41. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 42. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 43. India: National Estimation of Blood Requirement in India (2018)
  • Table 44. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 45. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 46. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 47. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 48. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 49. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 50. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 51. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 52. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 53. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 54. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 55. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 56. South and Central America Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 57. South and Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 58. South and Central America: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 60. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 61. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 62. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 63. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 64. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 65. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 66. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 67. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 68. Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 69. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 70. Middle East & Africa: Blood Transfusion Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. South Africa Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 72. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 73. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 74. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 75. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 76. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 77. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 78. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 79. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 80. Rest of Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 81. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 82. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • Table 83. Recent Inorganic Growth Strategies in the Blood Transfusion Diagnostics Market
  • Table 84. Recent Organic Growth Strategies in the Blood Transfusion Diagnostics Market
  • Table 85. Glossary of Terms

List Of Figures

  • Figure 1. Blood Transfusion Diagnostics Market Segmentation
  • Figure 2. Blood Transfusion Diagnostics Market - By Geography
  • Figure 3. Blood Transfusion Diagnostics Market Overview
  • Figure 4. Instruments and Kits Segment Held Largest Share by Type of Blood Transfusion Diagnostics Market
  • Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
  • Figure 6. Blood Transfusion Diagnostics Market, by Geography (US$ Million)
  • Figure 7. Global Blood Transfusion Diagnostics Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Blood Transfusion Diagnostics Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South & Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Impact Analysis
  • Figure 16. Global Blood Transfusion Diagnostics Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Blood Transfusion Diagnostics Market- Revenue Forecast And Analysis - 2021 - 2028
  • Figure 18. Global Blood Transfusion Diagnostics Market - Market Potential Analysis, By Region
  • Figure 19. Market Share Analysis of Key Players in Global Blood Transfusion Diagnostics Market
  • Figure 20. Global Blood Transfusion Diagnostics Market - Comparative Company Analysis
  • Figure 21. Global Blood Transfusion Diagnostics Market - Growth Strategy Analysis
  • Figure 22. Market positioning of Key Players in Blood Transfusion Diagnostics Market
  • Figure 23. Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
  • Figure 24. Instruments and Kits: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 25. Reagents: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 26. Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
  • Figure 27. Disease Screening: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 28. Blood Grouping: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 29. Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028 (%)
  • Figure 30. Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Hospitals: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 32. Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. North America: Blood Transfusion Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 35. North America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (USD Million)
  • Figure 36. North America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 37. US: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 38. Canada: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 39. Mexico: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 40. Europe: Blood Transfusion Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 41. Europe Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (USD Million)
  • Figure 42. Europe: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 43. Germany: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 44. UK: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 45. France: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 46. Italy: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 47. Spain: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 48. Rest of Europe: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 49. Asia Pacific Blood Transfusion Diagnostics Market Overview, by Country (2021)
  • Figure 50. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 51. Asia Pacific: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 52. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 53. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 54. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 55. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 56. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 57. Rest of Asia Pacific: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. South and Central America Blood Transfusion Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 59. South and Central America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. South and Central America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 61. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Rest of the South and Central America: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Middle East & Africa Blood Transfusion Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 65. Middle East & Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. Middle East & Africa: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 67. South Africa: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. UAE: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Rest of the Middle East and Africa: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Impact of COVID-19 Pandemic in North America Country Markets
  • Figure 72. Impact of COVID-19 Pandemic on European Country Markets
  • Figure 73. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 74. Impact of COVID-19 Pandemic in South and Central American Countries
  • Figure 75. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 76. Growth Strategies in the Blood Transfusion Diagnostics Market